Geen categorie

[siteorigin_widget]","after_widget":"</div>","before_title":"","after_title":"</h3>","widget_id":"widget-0-0-0"}}" />[/siteorigin_widget]If the restrictions to parallel trade were always justified, limited in time and scope, and properly implemented, no countries would experience the negative effects of exports, while all countries could experience the benefits of imports. This is the healthy parallel trade ecosystem we are advocating for.- Tanguy Schmitz -The COVID-19 pandemic has affected all aspects of the healthcare value chain, with some EU Member States banning parallel exports of certain “essential” drugs. How are BAPIE’s members adjusting to the current extraordinary times?As Belgian citizens wanting to provide an active contribution to this extraordinary crisis, our members have offered their purchasing…

When a medicine shortage occurs, patients — our loved ones — are the ones most affected. Parallel distribution can help fill the gap.  How? Say Belgium has a shortage. Parallel distributors fill the gap by taking surplus from other EU countries and delivering it to Belgium. Without this process, patients miss out on the medications they need to live a healthy, happy life. Parallel distribution means delivering medicine to the people who need it! Help #FillTheGap to support an open EU market for medication.

With the law of 7 April 2019, the Belgian legislator provided for a de facto export ban of medicines with a view to counter medicine shortages in Belgium. On 18 July 2019, the Belgian Constitutional Court already suspended the relevant provisions of the law of 7 April 2019. On 17 October 2019, the Court now also annulled the relevant provisions, stating that the current legal framework (if enforced) already provides for sufficient guarantees to avoid shortages of medicinal products on the Belgian market. Therefore the Court ruled that the provisions of the law of 7 April 2019 providing for a…

With the law of 7 April 2019, the Belgian legislator provided for a de facto export ban of medicines with a view to counter medicine shortages in Belgium. In a first judgement, the Belgian Constitutional Court acknowledged that the law is prima facie in breach with Articles 10 en 11 of the Belgian Constitution, read in conjunction with Articles 34 to 36 of the Treaty of the Functioning of the European Union, thereby considering that the current legal framework (if enforced) already provides for sufficient guarantees to avoid shortages. A final judgment on the annulment of the law is foreseen…